Expansion Opportunity Recent facility expansion and planned headcount increase indicate capacity for higher production of disinfection devices and syringe systems; a sales opportunity to offer additional lines, components, or contract manufacturing support to meet boosting demand.

Infection Control Leadership SwabCap and SwabFlush are award-winning, endorsed by major infection control groups; position for expanded adoption with hospitals and IDNs by offering complementary products, training packages, and bundled disinfection solutions.

Integrated Disinfection Unique combination products (SwabCap integrated into syringe plunger) present upsell potential to existing customers and distributors, plus opportunities to penetrate procurement with value-based offerings and compliance-driven purchasing.

ICU and Infusion Alignment Past acquisition by ICU Medical and focus on IV access disinfection align with large healthcare distributors and infusion therapy portfolios; target partner channels and co-marketing to penetrate broader hospital systems and outpatient infusion centers.

Growth Platform Moderate revenue scale with mid-size employee base suggests readiness for channel-driven growth; approach distributors and group purchasing organizations with scalable product kits, warranties, and after-sales support to accelerate adoption.